ANDA 78229, held by Wockhardt. Terbinafine Hydrochloride.
As of Nov 22, 2026, ANDA 78229 (Terbinafine Hydrochloride), held by Wockhardt, was first approved by FDA on Jul 2, 2007, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 2, 2007 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Terbinafine HydrochlorideEQ 250MG BASE · tablet;oral | Terbinafine Hydrochloride | Discontinued |
| Jun 24, 2010 | Supplement 4Labeling | Approved | None posted |
| Apr 22, 2009 | Supplement 3Labeling | Approved | None posted |
| Jul 2, 2007 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters